Adeona Announces Completion of 50% Enrollment in Trimesta(TM) Multiple ... - CNNMoney.com (press release)
Posted by admin! / Under Zinc Acetate
Adeona Announces Completion of 50% Enrollment in Trimesta(TM) Multiple ... CNNMoney.com (press release) Investigators at these clinical sites are administering either Trimesta™ along with glatimer acetate (Copaxone®), an FDA approved therapy for multiple ... |
Published on Thursday 11th of March 2010 08:07:07 PM
